The PANBioRA in silico platform for initial safety and efficacy prediction can be applied as a risk assessment tool for further lead development and optimization of the solution. The service is designed for the identification of the most perspective biomaterial from a group of similar compunds with a minimum number of steps and the least manipulation for further experimental investigations or risk assessment using sophisticated techniques.
Find out more about its functionality, market potential and broader impact in the full article here.